| type : |
Artikel |
| internetlink : |
https://doi.org/10.1007/s40123-022-00645-1 |
|
| onderzoeksgroepen : |
Incheon - Quality Evaluation Team, Samsung Bioepis Co |
| Auteur : |
Kaiser P.K, Yun J, Kim S, Kim J, Park S.J. |
| titel : |
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. |
| Nummer : |
Ophtalmol Ther ; 12:985–998. 2023 |
|
| Niveau van bewijs : |
|
| fysische stabiliteit : |
|
| chemische stabiliteit : |
|
| andere methoden : |
|
| Reacties : |
| Eiwit: biologische activiteit door celcultuur | | Eiwit: biologische activiteit door enzymatische techniek |
|
Stoffenlijst
 Ranibizumab
|
 |
 |
 |
 |
10 mg/ml |
28-32°C |
 |
| 60 |
 |
|
 |
|
 |
|
10 mg/ml |
2-8°C |
|
| 98 |
|
|
|
|
|
|
10 mg/ml |
23-27°C |
|
| 24 |
 |
|
|
|
 |
|
10 mg/ml |
2-8°C |
|
| 98 |
|
|
|
|
|
|
10 mg/ml |
23-27°C |
|
| 24 |
|
|
|
|
|
